Added to YB: 2026-09-09
Pitch date: 2026-09-07
CNTB [bullish]
Connect Biopharma Holdings Limited
-0.26%
current return
Author Info
No bio for this author
Company Info
Connect Biopharma Holdings Limited operates as a clinical-stage biopharmaceutical company in the United States.
Market Cap
$115.9M
Pitch Price
$1.92
Price Target
N/A
Dividend
N/A
EV/EBITDA
-1.23
P/E
-1.54
EV/Sales
28.78
Sector
Biotechnology
Category
special_situation
Week Ahead - Connect Biopharma Holdings Limited
CNTB: Connect Biopharma is a $1.89 IL-4Rα catalyst play, with topline acute-asthma data guided for early September and COPD results shortly afterward. Prior chronic-asthma data showed FEV1 gains and fewer exacerbations, supporting FDA clearance to advance that indication into Phase 3; cash is guided into 2H27. Success could create a differentiated acute-plus-chronic asset, but the readouts are binary and recent unexplained volatility warrants conservative sizing.
Read full article (2 min)